In vitro activity of dalbavancin and five comparator agents against common and uncommon Gram-positive organisms isolated from cancer patients.

about

Comparative efficacy and safety of antibiotics used to treat acute bacterial skin and skin structure infections: Results of a network meta-analysis.

P2860

Q47134431-73B09C55-D44E-4B0C-883E-8F11688E58B9

P2860

In vitro activity of dalbavancin and five comparator agents against common and uncommon Gram-positive organisms isolated from cancer patients.

Item

http://www.wikidata.org/entity/Q40252885

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

In vitro activity of dalbavanc ...... isolated from cancer patients.

@en

type

Item

label

In vitro activity of dalbavanc ...... isolated from cancer patients.

@en

prefLabel

In vitro activity of dalbavanc ...... isolated from cancer patients.

@en

P1476

In vitro activity of dalbavanc ...... isolated from cancer patients.

@en

P2093

Kenneth V I Rolston

http://www.w3.org/2001/XMLSchema#string

Randall A Prince

http://www.w3.org/2001/XMLSchema#string

Samuel A Shelburne

http://www.w3.org/2001/XMLSchema#string

Weiqun Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Hematologic effects of linezolid: summary of clinical experience.

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

The importance of bactericidal drugs: future directions in infectious disease.

Once-weekly dalbavancin versus daily conventional therapy for skin infection.

Vancomycin: a 50-year reassessment.

Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer.

Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance.

Current Microbiology of Surgical Site Infections in Patients with Cancer: A Retrospective Review

Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia

P2888

ja.2015.120

P304

381-387

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/JA.2015.120

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lior Nesher

P577

2015-12-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1038124811

http://www.w3.org/2001/XMLSchema#string

P698

26626876

http://www.w3.org/2001/XMLSchema#string

P921

Gram-positive bacteria

In vitro activity of dalbavancin and five comparator agents against common and uncommon Gram-positive organisms isolated from cancer patients.

about

P2860

P2860

In vitro activity of dalbavancin and five comparator agents against common and uncommon Gram-positive organisms isolated from cancer patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921